Skip to Main Content

Paper Details

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation
1
2023
Author NameAffiliation
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Mikhail KosiborodSt Luke's Mid America Heart Institute, University of Missouri-Kansas City (M.N.K.).
Carolyn S P LamNational Heart Centre Singapore and Duke-National University of Singapore (C.S.P.L.).
Adrian F HernandezDuke University School of Medicine
Adrian F HernandezDuke Clinical Research Institute, Duke University
  • 1 - 5

Datasets

Release 1.2